metastatike itari ntoya kuvura kanseri y'ibihaha

Kanseri y'ibihaha itari ntoya (mNSCLC) ni indwara igoye isaba ingamba zo kuvura yihariye. Aka gatabo gatanga incamake yuburyo bushya bwo kuvura, harimo kuvura intego, immunotherapie, chimiotherapie, hamwe n’igeragezwa ry’amavuriro, guha ubushobozi abarwayi nimiryango yabo bafite ubumenyi bwo gufata ibyemezo byuzuye. Kumva Kanseri yibihaha ya Metastatike itari nto.Kanseri y'ibihaha itari ntoya, bizwi kandi nk'icyiciro cya IV NSCLC, bivuze ko kanseri yakwirakwiriye mu bihaha igera mu bindi bice by'umubiri. Ahantu hakunze kuboneka metastasis harimo ubwonko, amagufwa, umwijima, na glande ya adrenal. Nubwo kanseri metastatike ishobora kugorana kuyivura, gutera imbere muburyo bwo kuvura byahinduye cyane umusaruro nubuzima bwiza kubarwayi benshi. Kwipimisha hakiri kare ni ngombwa, kandi urashobora kwiga byinshi kubyerekeye ubushakashatsi bwa kanseri mu kigo cy’ubushakashatsi bwa kanseri ya Shandong Baofa. Ubwoko bwa Kanseri y'ibihaha itari mito mito Ubwoko bubiri bw'ingenzi bwa NSCLC ni adenocarcinoma na kanseri y'udukoko twa kanseri. Adenocarcinoma nubwoko bukunze kugaragara kandi bukunze kugaragara kubatanywa itabi. Indwara ya kanseri ya kanseri ikunze guhuzwa no kunywa itabi. Ubundi bwoko budakunze kuboneka harimo kanseri nini ya kanseri na kanseri ya adenosquamous. Gusuzuma neza subtype ni ngombwa kugirango hamenyekane uburyo bwiza bwo kuvura.Gusuzuma na StageGusuzuma metastatike itari ntoya kuvura kanseri y'ibihaha mubisanzwe birimo guhuza ibizamini byerekana amashusho (CT scan, PET scan, MRI), biopsies, hamwe no gupima molekile. Igeragezwa rya molekuline risesengura kanseri ya kanseri yihariye ihindagurika cyangwa ibinyabuzima bishobora kwibasirwa nubuvuzi bwihariye. Gutegura byerekana urugero rwa kanseri ikwirakwira, ifasha abaganga guhuza gahunda yo kuvura. metastatike itari ntoya kuvura kanseri y'ibihaha mubisanzwe sisitemu, bivuze ko igira ingaruka kumubiri wose. Uburyo rusange bwo kuvura burimo: Targeted Therapy Imiti igamije kuvura yibasira cyane molekile zimwe na zimwe (nka poroteyine cyangwa gen) zifasha kanseri ikura no gukwirakwira. Ubu buryo bwo kuvura bukoreshwa kenshi mu barwayi bafite ibibyimba bifite ihindagurika ry’imiterere yihariye. Inhibitor zisanzwe za EGFR zirimo: Osimertinib (Tagrisso) Erlotinib (Tarceva) Gefitinib (Iressa) Afatinib (Gilotrif) Iyi miti ibuza poroteyine ya EGFR, ikabuza ingirabuzimafatizo za kanseri gukura. Inzitizi zisanzwe za ALK zirimo: Alectinib (Alecensa) Brigatinib (Alunbrig) Ceritinib (Zykadia) Crizotinib (Xalkori) Iyi miti ibuza poroteyine ALK, gutinda cyangwa guhagarika imikurire ya kanseri. Oncologue wawe azagaragaza niba kanseri yawe ifite imwe muriyo ihinduka.ImmunotherapyImmunotherapy imiti ifasha sisitemu yumubiri wawe kumenya no gutera selile. Ubu buryo bwo kuvura bukoreshwa nkumurongo wambere wo kuvura kuri metastatike itari ntoya kuvura kanseri y'ibihaha.PD-1 na PD-L1 InhibitorIyi miti ihagarika poroteyine PD-1 (progaramu ya progaramu ya progaramu ya selile 1) cyangwa PD-L1 (progaramu ya selile y'urupfu ya ligand 1), ifasha selile kanseri kwirinda ubudahangarwa bw'umubiri. Inzitizi zisanzwe za PD-1 na PD-L1 zirimo: Pembrolizumab (Keytruda) Nivolumab (Opdivo) Atezolizumab (Tecentriq) Durvalumab (Imfinzi) - Akenshi ikoreshwa nyuma ya chemoradiation mu cyiciro cya III NSCLC.Iyi miti irashobora gukoreshwa wenyine cyangwa ifatanije na chimiotherapie CTTLA-4 Inhibitor poroteyine 4) poroteyine, ifasha kandi selile kanseri kwirinda ubudahangarwa bw'umubiri. Ipilimumab (Yervoy) ni inhibitor ya CTLA-4 isanzwe, rimwe na rimwe ikoreshwa ifatanije na PD-1 inhibitor. Imiti ya chimiotherapie Imiti ya chimiotherapie ikoresha imiti ikomeye yica kanseri. Mugihe ubuvuzi bugamije hamwe nubudahangarwa bwiganje cyane, chimiotherapie ikomeza kuba uburyo busanzwe bwo kuvura, cyane cyane bufatanije nubundi buvuzi. Imiti isanzwe ya chimiotherapie ikoreshwa kuri metastatike itari ntoya kuvura kanseri y'ibihaha harimo: Imiti ishingiye kuri platine (Cisplatin, Carboplatin) Tagisi (Paclitaxel, Docetaxel) Pemetrexed (Alimta) Gemcitabine (Gemzar) Imishwarara y’imiti ivura imirasire ikoresha ingufu nyinshi mu kwica selile. Bikunze gukoreshwa mu kugabanya ibimenyetso nkububabare cyangwa guhumeka neza mugihe kanseri imaze gukwirakwira ahantu runaka nkamagufwa cyangwa ubwonko. Irashobora kandi gukoreshwa mukuvura ibibyimba byibanze by ibihaha. Kubaga Ubusanzwe ntabwo aribwo buryo bwambere bwo kuvura metastatike itari ntoya kuvura kanseri y'ibihaha, ariko irashobora gukoreshwa mubihe bimwe bimwe kugirango ikureho metastasis imwe, cyane cyane mubwonko cyangwa glande ya adrenal. Ibi bikunze kuba muri gahunda yuzuye yo kuvura.Igeragezwa rya Clinical Ibigeragezo bya kliniki ni ubushakashatsi bwubushakashatsi bugerageza kuvura kanseri nshya. Baha abarwayi uburyo bwo kuvura bugezweho butaraboneka henshi. Tekereza kuganira na muganga wawe. Shandong Baofa Ikigo Cy’ubushakashatsi cya Kanseri kigira uruhare rugaragara kandi kigateza imbere ubushakashatsi ku mavuriro. Gucunga Ingaruka Zishobora Kuvura kanseri bishobora gutera ingaruka. Muganga wawe arashobora kugufasha gucunga izo ngaruka ukoresheje imiti nubundi buvuzi bufasha. Ingaruka zisanzwe zirimo umunaniro, isesemi, ububabare, no guta umusatsi. Nibyingenzi kumenyekanisha ingaruka zose uhura nazo kubitsinda ryanyu ryubuzima.Ibipimo byo Kumenyekanisha no KurokokaIbipimo bya metastatike itari ntoya kuvura kanseri y'ibihaha biratandukanye bitewe nibintu byinshi, harimo icyiciro cya kanseri, ubuzima bwumurwayi muri rusange, nubuvuzi bwihariye bwakiriwe. Mugihe indwara ikunze gutera imbere, ibipimo byo kubaho byateye imbere cyane hamwe niterambere ryimiti mishya. Muganire ku muntu ku giti cye hamwe na oncologue wawe.Palliative CarePalliative care yibanda ku kugabanya ibimenyetso no kuzamura imibereho y’abarwayi bafite uburwayi bukomeye, harimo na kanseri y'ibihaha metastatike. Irashobora gutangwa murwego urwo arirwo rwose rwindwara, kandi ikoreshwa kenshi hamwe nubundi buvuzi. Ubuvuzi bwa Palliative burashobora gufasha gucunga ububabare, guhumeka neza, umunaniro, nibindi bimenyetso. Ibitekerezo byingenzi byo gufata ibyemezo byo kuvura Guhitamo uburyo bwiza bwo kuvura metastatike itari ntoya kuvura kanseri y'ibihaha nicyemezo kitoroshye kigomba gufatwa mubyumvikanyeho na oncologue wawe. Dore bimwe mubyingenzi byingenzi: Ibisubizo by'ibizamini bya molekulari: Gusobanukirwa ihinduka ryimiterere ihindagurika cyangwa biomarkers muri selile yawe ya kanseri ningirakamaro kugirango umenye niba imiti igamije ari amahitamo. Muri rusange Ubuzima: Urwego rusange rwubuzima nubuzima bwiza bizagira ingaruka kumiti ikwiye. Intego zo kuvura: Muganire ku ntego zawe zo kuvura na muganga wawe, niba ari ukongera ubuzima, kuzamura imibereho, cyangwa byombi. Ingaruka zo ku ruhande: Sobanukirwa n'ingaruka zishobora guterwa na buri buryo bwo kuvura nuburyo zishobora gucungwa. Ibigeragezo bivura: Reba niba kwitabira ikizamini cyamavuriro bikubereye.Iterambere ryanyuma mukuvura kanseri yibihaha Urwego rwo kuvura kanseri yibihaha rugenda rwiyongera. Ubuvuzi bushya nuburyo bukomeza gutezwa imbere. Amwe mumajyambere agezweho arimo: Antibody-ibiyobyabwenge conjugate (ADCs): Iyi miti ihuza umwihariko wubuvuzi bugamije hamwe nimbaraga zica selile ya chimiotherapie. Antibodies zidasanzwe: Izi antibodies zifata ingirabuzimafatizo zo kurwanya kanseri. Uburyo bunoze bwo gukoresha imirasire: Ubuhanga nka stereotactique yumubiri wumuriro (SBRT) utanga urugero rwinshi rwimirase yibibyimba mugihe ugabanya kwangirika kwingirangingo zikikije.Kubaho hamwe na Metastatike Atari Utugingo ngengabuzima Kanseri yibihahaKubaho hamwe metastatike itari ntoya kuvura kanseri y'ibihaha birashobora kuba ingorabahizi, ariko hariho ibikoresho byinshi byafasha abarwayi nimiryango yabo. Amatsinda atera inkunga, ubujyanama, hamwe nabantu kumurongo barashobora gutanga inkunga yamarangamutima ninama zifatika. Kugumana ubuzima buzira umuze, harimo indyo yuzuye hamwe na siporo isanzwe, birashobora kandi kuzamura imibereho. Inshingano: Aya makuru agenewe ubumenyi rusange nintego zamakuru gusa, kandi ntabwo bigize inama zubuvuzi. Ni ngombwa kugisha inama inzobere mu by'ubuzima zibishoboye kubibazo byose byubuzima cyangwa mbere yo gufata ibyemezo byose bijyanye n'ubuzima bwawe cyangwa kwivuza.Ibikoresho byo hanze:Sosiyete y'Abanyamerika ya Kanseri - Kuvura Kanseri y'ibihaha itari ntoyaKanseri.Net - Kanseri y'ibihaha - Akagari kitari gito - Uburyo bwo kuvuraNational Comprehensive Cancer Network (NCCN) - Non-Small Cell Lung Cancer Guidelines for Patients (PDF)Reba: Amakuru namakuru yatanzwe ashingiye kubumenyi bwubuvuzi bugezweho kandi bukomoka mumiryango yubuvuzi izwi guhera 26 Ukwakira 2023.